A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

Clinical trial NCT01995071 · COMPLETED

Trial details

NCT number: NCT01995071
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C Hepatitis C Virus Compensated Cirrhosis

Start date: 2013-11-01
Primary completion: 2015-06-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.